2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Intravitreal injection: new trials by email Literature Review of Intravitreal injection trials Research Report on Intravitreal injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START Intravitreal injection - Neovascular Age-related Macular Degeneration of All Subtypes | Phase 4 | Completed | University Hospital, Bordeaux | 50 | 2014-09-01 | 2026-09-17 |
| Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept intravitreal injection - Exudative Age-related Macular Degeneration | Phase 4 | Completed | Oslo University Hospital | 16 | 2014-04-01 | 2022-04-27 |
Oslo University Hospital (1) · University Hospital, Bordeaux (1)
France (1)
2014 (1)